Parkside Financial Bank & Trust’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.8K | Buy |
2,347
+375
| +19% | +$10.3K | 0.01% | 805 |
|
|
2025
Q1 | $55.9K | Buy |
1,972
+100
| +5% | +$2.84K | 0.01% | 790 |
|
|
2024
Q4 | $77.8K | Buy |
1,872
+624
| +50% | +$25.9K | 0.01% | 664 |
|
|
2024
Q3 | $83.4K | Sell |
1,248
-165
| -12% | -$11K | 0.01% | 605 |
|
|
2024
Q2 | $168K | Buy |
1,413
+260
| +23% | +$30.9K | 0.03% | 388 |
|
|
2024
Q1 | $123K | Buy |
1,153
+595
| +107% | +$63.4K | 0.02% | 467 |
|
|
2023
Q4 | $55.5K | Sell |
558
-7
| -1% | -$696 | 0.01% | 651 |
|
|
2023
Q3 | $58.4K | Buy |
565
+175
| +45% | +$18.1K | 0.01% | 572 |
|
|
2023
Q2 | $47.4K | Sell |
390
-59
| -13% | -$7.17K | 0.01% | 635 |
|
|
2023
Q1 | $69K | Buy |
449
+1
| +0.2% | +$154 | 0.02% | 484 |
|
|
2022
Q4 | $80.5K | Buy |
448
+207
| +86% | +$37.2K | 0.02% | 435 |
|
|
2022
Q3 | $29K | Sell |
241
-130
| -35% | -$15.6K | 0.01% | 688 |
|
|
2022
Q2 | $53K | Buy |
371
+62
| +20% | +$8.86K | 0.02% | 504 |
|
|
2022
Q1 | $53K | Buy |
309
+196
| +173% | +$33.6K | 0.01% | 529 |
|
|
2021
Q4 | $29K | Sell |
113
-152
| -57% | -$39K | 0.01% | 691 |
|
|
2021
Q3 | $102K | Buy |
265
+214
| +420% | +$82.4K | 0.03% | 322 |
|
|
2021
Q2 | $12K | Sell |
51
-42
| -45% | -$9.88K | ﹤0.01% | 914 |
|
|
2021
Q1 | $12K | Sell |
93
-2
| -2% | -$258 | ﹤0.01% | 882 |
|
|
2020
Q4 | $10K | Buy |
95
+8
| +9% | +$842 | ﹤0.01% | 885 |
|
|
2020
Q3 | $6K | Buy |
87
+60
| +222% | +$4.14K | ﹤0.01% | 894 |
|
|
2020
Q2 | $2K | Buy |
+27
| New | +$2K | ﹤0.01% | 1181 |
|